West Tower Group’s Labcorp LH Stock Holding History

West Tower Group’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,180	Closed	-$1.02M	–	583
2023 Q1	$1.02M	Buy	+5,180	New	+$1.07M	1.01%	41

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

West Tower Group's LH Position: Q2 2023 in Review

West Tower Group sold out of Labcorp (LH) in Q2 2023, closing a stake of 5,180 shares — an estimated $1.02M sold.

West Tower Group first reported a position in LH in Q1 2023 and held it in 1 quarter. The position peaked at $1.02M in Q1 2023. 932 funds tracked by Wall St. Rank hold LH as of Q2 2023.

West Tower Group reported no remaining Labcorp position as of Q2 2023 after selling out during the quarter.
West Tower Group sold 5,180 Labcorp shares in Q2 2023, an estimated $1.02M.
West Tower Group first reported a position in Labcorp in Q1 2023 and held it in 1 quarter.
West Tower Group's Labcorp position peaked at $1.02M in Q1 2023.
932 funds tracked by Wall St. Rank held Labcorp as of Q2 2023.

Based on West Tower Group's 13F filing for Q2 2023, filed 14 Aug 2023.